These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 6285019

  • 21. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)].
    Ikemoto H, Watanabe K, Kosakai N, Hayashi Y, Oguri T, Saito A, Shinohara M, Matsumiya H, Ueda K, Ida S.
    Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915
    [Abstract] [Full Text] [Related]

  • 22. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [Abstract] [Full Text] [Related]

  • 23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F.
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [Abstract] [Full Text] [Related]

  • 24. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
    Matsuoka A, Sumi K, Yoshimoto H, Takase M, Takashima S, Mimura K.
    Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
    [Abstract] [Full Text] [Related]

  • 25. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K, Kawamura S, Sugita R, Fujimaki Y, Ohsawa H.
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [Abstract] [Full Text] [Related]

  • 26. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y, Okimura Y, Horiuchi N, Kanai M.
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract] [Full Text] [Related]

  • 27. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N.
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [Abstract] [Full Text] [Related]

  • 28. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kawaguchi H, Shimizu Y, Matsumiya H, Saito A, Terai T, Inoue H, Nakadate T, Ito C, Yosida T, Tanno Y, Ohno I, Nishioka K, Arakawa M, Igarashi K, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Touyama M.
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [Abstract] [Full Text] [Related]

  • 29. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [Abstract] [Full Text] [Related]

  • 30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
    Kosakai N, Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
    [Abstract] [Full Text] [Related]

  • 31. [Laboratory and clinical studies on ceftazidime in the field of pediatrics].
    Kuno K, Yafuso M, Miyachi Y, Nakashima T, Ichihara K, Ueda S.
    Jpn J Antibiot; 1984 Mar; 37(3):469-84. PubMed ID: 6376856
    [Abstract] [Full Text] [Related]

  • 32. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K, Fukayama S, Nishimura Y, Nishike A, Oda S, Sato S, Matsumoto Y, Ikegami R, Yokota N, Tanaka S.
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [Abstract] [Full Text] [Related]

  • 33. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P, Bryskier A, Le Noc D.
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [Abstract] [Full Text] [Related]

  • 34. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
    Deguchi K, Fukayama S, Nishimura Y, Yokota N, Tanaka S, Oda S, Matsumoto Y, Ikegami R, Satoh K, Toyonaga Y.
    Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
    [Abstract] [Full Text] [Related]

  • 35. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N, Kumamoto Y, Sakai S, Hirose T, Shigeta S, Shiraiwa Y, Miura Y, Ogata M, Tazaki H, Iri H.
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [Abstract] [Full Text] [Related]

  • 36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). III. Secular changes in susceptibility].
    Kosaki N, Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1989 Oct; 42(10):2189-312. PubMed ID: 2607604
    [Abstract] [Full Text] [Related]

  • 37. [Experimental and clinical studies on cefoperazone (author's transl)].
    Toyonaga Y, Kurosu Y, Yoshikawa H, Kumagai K, Takahashi T, Hori M.
    Jpn J Antibiot; 1980 Aug; 33(8):820-40. PubMed ID: 6451729
    [Abstract] [Full Text] [Related]

  • 38. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H.
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [Abstract] [Full Text] [Related]

  • 39. [Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
    Asari S, Horikawa M, Tsukamoto H, Shimizu Y, Koda K, Hayashi C, Miyai K.
    Jpn J Antibiot; 1984 Feb; 37(2):267-78. PubMed ID: 6330393
    [Abstract] [Full Text] [Related]

  • 40. [Antimicrobial activity of cefotiam against various clinical isolates from 1981 to 1985].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1986 Aug; 39(8):1981-7. PubMed ID: 3467078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.